Autoryzacja wymagana
RHD deletion in a patient with chronic myeloid leukemia
, , , , , , oraz
25 mar 2020
O artykule
Kategoria artykułu: Case Report
Data publikacji: 25 mar 2020
Zakres stron: 160 - 164
DOI: https://doi.org/10.21307/immunohematology-2019-291
Słowa kluczowe
© 2008 A. Murdock, et al., published by Sciendo
Murdock, A.
Good Samaritan Hospital Medical CenterWest Islip, NY
Assip, D.
Good Samaritan Hospital Medical CenterWest Islip, NY
Hue-Roye, K.
Laboratory of Immunochemistry, New York Blood CenterNew York, NY
Lomas-Francis, C.
Laboratory of Immunohematology, New York Blood CenterLong Island City, NY
Hu, Z.
Laboratory of Immunohematology, New York Blood CenterLong Island City, NY
Vege, S.
Molecular Blood Group and Platelet Testing Laboratory, American Red CrossPhiladelphia, PA
Westhoff, C.M.
Molecular Blood Group and Platelet Testing Laboratory, American Red CrossPhiladelphia, PA
Reid, M.E.
New York Blood CenterNew York, NY